Alcinous Pharmaceuticals
About:
Alcinous Pharmaceuticals designs and develops new molecules that modulate the activity of well-established protein targets.
Website: https://www.alcinouspharmaceuticals.com/
Top Investors: Slater Technology Fund
Description:
Alcinous Pharmaceuticals designs and develops new molecules that modulate the activity of well-established protein targets related to oncology and other pathologies.
Total Funding Amount:
$600000
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Rumford, Rhode Island, United States
Founded Date:
2016-01-01
Founders:
Kenneth Rose, Nicholas DaSilva
Number of Employees:
1-10
Last Funding Date:
2020-05-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai